Myocardial cell damage in human hypertension

Journal of the American College of Cardiology

Volumn 36, Issue 7, 2000, Pages 2198-2203

  Pons Lladó, Guillem ^a   Ballester, Manel ^a   Borrás, Xavier ^a   Carreras, Francesc ^a   Carrió, Ignasi ^a   López Contreras, Joaquin ^a   Roca Cusachs, Alex ^a   Marrugat, Jaume ^b   Narula, Jagat ^c  

^a HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

^c ALLEGHENY UNIVERSITY HOSPITALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYOSIN ANTIBODY IN 111;

ADULT; AGED; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; DIAGNOSTIC IMAGING; DISEASE SEVERITY; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL;

AGED; ANTIBODIES, MONOCLONAL; CELL DEATH; DISEASE PROGRESSION; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; INDIUM RADIOISOTOPES; MALE; MIDDLE AGED; MYOCARDIUM; ORGANOMETALLIC COMPOUNDS; REGRESSION ANALYSIS; STROKE VOLUME; VENTRICULAR FUNCTION, LEFT;

EID: 0033666289     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00983-9     Document Type: Article

References (53)

1. The role of hypertension in the pathogenesis of heart failure: A clinical mechanistic overview
2. The natural history of congestive heart failure: The Framingham Heart Study
3. Trends in the prevalence, awareness, treatment and control of hypertension in the adult US population: Data from the health examination surveys, 1960-1991
4. Left ventricular hypertrophy by electrocardiogram: Prevalence, incidence and mortality in the Framingham study
5. Hypertension detection and follow-up program: Baseline electrocardiographic characteristics of the hypertensive participants
6. Left ventricular hypertrophy and function in high, normal and low renin forms of hypertension
7. Exercise radionuclide ventriculographic responses in hypertensive patients with chest pain
8. Relation of obesity, high sodium intake and eccentric left ventricular hypertrophy to left ventricular exercise dysfunction in essential hypertension
9. Assessment of left ventricular function by midwall fractional shortening/end-systolic stress relationship in human hypertension
10. Morphology of the heart in left ventricular hypertrophy
11. Ultrastructral features of degenerated cardiac muscle cells in patients with cardiac hypertrophy
12. Myocardial injury: Quantitation by cell sorting initiated with antimyosin fluorescent spheres
13. Myocardial infarct imaging with antibodies to canine cardiac myosin with DTPA
14. Acute myocardial infarct imaging with technetium-99m and indium-111 antimyosin Fab
15. 111Indium-antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection
16. Recognition of acute myocarditis masquerading as acute myocardial infarction
17. 111In-monoclonal antimyosin antibody studies after the first year of heart transplantation. Identification of risk groups for developing rejection during long-term follow-up and clinical implications
18. High prevalence of ongoing myocyte damage in patients with chronic dilated cardiomyopathy
19. Active myocardial damage without attending inflammatory response in idiopathic dilated cardiomyopathy
20. Spectrum of alcohol-induced myocardial necrosis detected by 111In-monoclonal antimyosin antibodies
21. Detection of doxorubicin cardiotoxicity in patients with sarcomas by Indium-111-antimyosin monoclonal antibody studies
22. Evaluation of myocardial cell damage by In-111 monoclonal antimyosin antibodies in patients under chronic tricyclic antidepressant drug treatment
23. Committee on M-mode echocardiography of the American Society of Echocardiography. Recommendations regarding quantitation in M-Mode echocardiography: Results of survey of echocardiographic measurements
24. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
25. An integrated approach to the noninvasive assessment of left ventricular systolic and diastolic performance
26. 111In-monoclonal antimyosin antibody imaging
27. On the mechanism of compensatory hyperfunction and insufficiency of the heart
28. Wall stress and patterns of hypertrophy in the human left ventricle
29. Myocite death and ventricular remodeling
30. Extracellular matrix remodeling in heart failure: A role for de novo angiotensin II generation
31. Cardiomyopathy of overload: A major determinant of prognosis in congestive heart failure
32. The cardiomyopathy of overload: An unnatural growth response in the hypertrophied heart
33. The cardiomyopathy of overload: An unnatural growth response
34. Acute myocardial infarct imaging with Indium-111-labeled monoclonal antimyosin Fab
35. Myocardial blood flow distribution in patients with ischemic heart disease or dilated cardiomyopathy undergoing heart transplantation
36. Effects of short- and long-term left ventricular hypertrophy on coronary circulation
37. Cardiac hypertrophy and ventricular remodeling
38. Apoptosis in myocytes in end-stage heart failure
39. Apoptosis and the heart
40. Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics
41. Stretching cardiomyocytes stimulates proto-oncogene expression
42. Integrins: Versatility, modulation and signaling in cell adhesion
43. 1] angiotensin-II receptor-mediated stimulation of protein synthesis in chick heart cells
44. Angiotensin II and left ventricular growth in newborn pig heart
45. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro
46. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat
47. Apoptosis in hypertensive heart disease
48. Burden of myocardial damage in cardiac allograft rejection: Histologic evidence of myocyte necrosis and apoptosis and scintigraphic evidence of antimyosin uptake
49. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats
50. Effects of Enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandanavian Enalapril Survival Study (CONSENSUS)
51. Effects of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
52. Effect of carvedilol on mortality and morbidity in chronic heart failure
53. Medical therapy can improve the biological properties of the chronically failing heart: A new era in the treatment of heart